New service allows pharmacies to benefit from McKesson’s central fill automation and industry expertise with little to no upfront cost
MALVERN, Pa., December 2, 2016—McKesson Corporation’s High Volume Solutions group is pleased to announce the launch of Central Fill as a Service™ (CFaaS) at the ASHP Midyear 2016 Clinical Meeting & Exhibition in Las Vegas, Nev., December 4-8, 2016. CFaaS is a McKesson-operated, centralized solution that allows pharmacies to use central fill without the investment in equipment, inventory, or staffing (other than a pharmacist). Instead of the traditional central fill model that requires significant upfront investment, CFaaS is available to customers through a per-prescription fee that can dramatically reduce the pharmacy’s per-prescription cost to dispense.
With Central Fill as a Service, McKesson has combined its products and services into a value-added portfolio that addresses increasingly complex market challenges for its customers. CFaaS incorporates McKesson’s industry-leading Central Fill pharmacy automation technology and operational expertise, integrated pharmacy workflow, vast pharmaceutical distribution network, and patent-pending streamlined 340B ordering and inventory capabilities to create new revenue and cost savings opportunities for pharmacies that may not have the resources to build their own central fill facility. A team of McKesson High Volume Solutions pharmacy automation experts will work with each CFaaS customer to tailor the service to meet their specific business objectives.
For health system outpatient pharmacies, access to a central fill facility can help improve per capita costs and free staff to focus on population health and experience of care. By capturing fills on discharge and retaining them after discharge, the pharmacy can create medication adherence and counseling programs to improve patient health outcomes and reduce readmission rates.
Small chain pharmacies can benefit from CFaaS through increased efficiencies, reduced costs, and a greater focus on patient care. This differentiation for small chains can help show value in patient care through a focus on payer performance criteria, including medication adherence. Pharmacies that already operate a central fill facility in need of an upgrade may benefit from CFaaS as an alternative to investing capital in new or additional equipment. In addition, pharmacies can use the service to increase revenue by pursuing business in new markets such as Employee Fills, Mail Order, Specialty, 340B or Long Term Care (LTC).
“We are excited to offer this new service to our customers who traditionally have not been able to take advantage of our Central Fill solutions,” said Joe Tammaro, VP Sales, McKesson High Volume Solutions. “Central Fill as a Service allows our customers to benefit from a combination of many assets and tools available from McKesson, including distribution, inventory optimization, industry-leading pharmacy management systems, 340B inventory management, and extensive central fill operational expertise.”
For more information on Central Fill as a Service, please contact McKesson High Volume Solutions at HVSinquiries@McKesson.com.